Uganda HIV/TB COHRE Training Program
乌干达艾滋病毒/结核病 COHRE 培训计划
基本信息
- 批准号:6915690
- 负责人:
- 金额:$ 29.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-06-28 至 2009-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Although the seroprevalence of HIV has declined in Uganda over the past 10 years, the HIV epidemic in Uganda is far from controlled. In the face of the HIV epidemic, tuberculosis rates are high and associated with significant mortality. With the advent of antiretroviral therapy, prevention strategies alone are no longer sufficient to meet the current needs in Uganda. There is now a moral imperative to bring the remarkable advances in the field of HIV to developing countries like Uganda. One key step in the rebuilding of the Ugandan public health infrastructure resulted from a unique collaboration between the Ugandan Ministry of Health, the Ministry of Defense and Makerere University to form the Joint Clinical Research Center (JCRC). The JCRC is a research and health care facility devoted entirely to HIV and leads the way in opening Africa to antiretroviral therapy. Through the years, the JCRC has formed strong collaborations with Case Western Reserve University (CWRU), the National Tuberculosis and Leprosy Control Programme (NTLP), Makerere and Mbarara Universities. The proposed training program will build on these strong relationships with the common mission of controlling HIV and TB. The goals of this training program are to expand the national capacity to address the public health and scientific challenges of the evolving HIV and TB epidemic in Uganda through clinical, operational and health services research. Through this training program Uganda will build the capacity to translate basic and clinical research findings into public health policy and interventions, and to evaluate their effectiveness. The training program will build on a growing number of clinical research projects on HIV and TB, but will extend the findings of these studies to the public health and policy arena. The goals will be met through a coherent program of degree and non-degree training in collaboration with CWRU, that will strengthen the capacity in Uganda to conduct integrated clinical, operational and health services research related to HIV and TB. The research training in this program will be linked to the ongoing research and program activities at the JCRC in Kampala, Uganda, CWRU, in the US, Mbarara University of Sciences and Technology, NTLP, Kampala City Council, CDC, USAID and Elizabeth Glaser Pediatric Foundation.
描述(由申请人提供):尽管乌干达的艾滋病毒血清流行率在过去十年中有所下降,但乌干达的艾滋病毒流行仍远未得到控制。面对艾滋病毒流行,结核病发病率很高,死亡率很高。随着抗逆转录病毒疗法的出现,仅靠预防策略已不足以满足乌干达当前的需求。现在,将艾滋病毒领域的显着进展带给乌干达这样的发展中国家是道义上的当务之急。乌干达公共卫生基础设施重建的关键一步是乌干达卫生部、国防部和马凯雷雷大学之间独特的合作,组建了联合临床研究中心(JCRC)。 JCRC 是一家完全致力于艾滋病毒研究和医疗保健机构,在非洲开展抗逆转录病毒治疗方面处于领先地位。多年来,JCRC 与凯斯西储大学 (CWRU)、国家结核病和麻风病控制计划 (NTLP)、麦克雷雷大学和姆巴拉拉大学建立了强有力的合作。拟议的培训计划将建立在与控制艾滋病毒和结核病的共同使命的这些牢固关系的基础上。该培训计划的目标是通过临床、业务和卫生服务研究,扩大国家能力,应对乌干达不断演变的艾滋病毒和结核病流行所带来的公共卫生和科学挑战。通过该培训计划,乌干达将建立将基础和临床研究成果转化为公共卫生政策和干预措施并评估其有效性的能力。该培训计划将以越来越多的艾滋病毒和结核病临床研究项目为基础,并将这些研究的结果扩展到公共卫生和政策领域。这些目标将通过与 CWRU 合作的连贯的学位和非学位培训计划来实现,这将加强乌干达开展与艾滋病毒和结核病相关的综合临床、业务和卫生服务研究的能力。该项目的研究培训将与乌干达坎帕拉 JCRC、美国 CWRU、姆巴拉拉科技大学、NTLP、坎帕拉市议会、疾病预防控制中心、美国国际开发署和伊丽莎白格拉泽儿科基金会正在进行的研究和项目活动联系起来。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christopher C. Whalen其他文献
Linkage and association analysis of candidate genes for TB and TNFα cytokine expression: evidence for association with IFNGR1, IL-10, and TNF receptor 1 genes
- DOI:
10.1007/s00439-007-0357-8 - 发表时间:
2007-04-13 - 期刊:
- 影响因子:3.600
- 作者:
Catherine M. Stein;Sarah Zalwango;Allan B. Chiunda;Christopher Millard;Dmitry V. Leontiev;Amanda L. Horvath;Kevin C. Cartier;Keith Chervenak;W. Henry Boom;Robert C. Elston;Roy D. Mugerwa;Christopher C. Whalen;Sudha K. Iyengar - 通讯作者:
Sudha K. Iyengar
Clinical course of human immunodeficiency virus type 1 associated pulmonary tuberculosis during short-course antituberculosis therapy.
短期抗结核治疗期间人类免疫缺陷病毒 1 型相关肺结核的临床过程。
- DOI:
- 发表时间:
1997 - 期刊:
- 影响因子:0
- 作者:
S. Schwander;S. Schwander;M. Dietrich;PETER N. Mugyenyi;C. Kityo;A. Okwera;John L. Johnson;P. Nsubuga;S. Ruesch;Christopher C. Whalen - 通讯作者:
Christopher C. Whalen
Instability of tuberculin and Candida skin test reactivity in HIV-infected Ugandans. The Uganda-Case Western Reserve University Research Collaboration.
感染艾滋病毒的乌干达人结核菌素和念珠菌皮试反应性不稳定。
- DOI:
- 发表时间:
1998 - 期刊:
- 影响因子:24.7
- 作者:
John L. Johnson;S. Nyole;A. Okwera;Christopher C. Whalen;P. Nsubuga;Vukosava Pekovic;Robin Huebner;Robert S. Wallis;PETER N. Mugyenyi;R. Mugerwa;J. Ellner - 通讯作者:
J. Ellner
Risk factors for adverse drug reactions during thiacetazone treatment of pulmonary tuberculosis in human immunodeficiency virus infected adults.
人类免疫缺陷病毒感染成人硫醋酮治疗肺结核期间药物不良反应的危险因素。
- DOI:
- 发表时间:
1997 - 期刊:
- 影响因子:0
- 作者:
A. Okwera;John L. Johnson;M. Vjecha;K. Wolski;Christopher C. Whalen;David L. Hom;R. Huebner;R. Mugerwa;J. Ellner - 通讯作者:
J. Ellner
Christopher C. Whalen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christopher C. Whalen', 18)}}的其他基金
Digital Mobile Technologies to study Tuberculosis: A Multi-disciplinary Program
研究结核病的数字移动技术:一个多学科项目
- 批准号:
10676557 - 财政年份:2023
- 资助金额:
$ 29.55万 - 项目类别:
Computational and Molecular Epidemiology Training in TB and HIV in Uganda
乌干达结核病和艾滋病毒计算和分子流行病学培训
- 批准号:
9301687 - 财政年份:2015
- 资助金额:
$ 29.55万 - 项目类别:
Computational and Molecular Epidemiology Training in TB and HIV in Uganda
乌干达结核病和艾滋病毒计算和分子流行病学培训
- 批准号:
9097840 - 财政年份:2015
- 资助金额:
$ 29.55万 - 项目类别:
Community Transmission of Tuberculosis Urban Africa
非洲城市结核病的社区传播
- 批准号:
9761955 - 财政年份:2012
- 资助金额:
$ 29.55万 - 项目类别:
Community Transmission of Tuberculosis Urban Africa
非洲城市结核病的社区传播
- 批准号:
10226961 - 财政年份:2012
- 资助金额:
$ 29.55万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 29.55万 - 项目类别:
Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 29.55万 - 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 29.55万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 29.55万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 29.55万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 29.55万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 29.55万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 29.55万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 29.55万 - 项目类别:
Mentoring Scientists for Careers in HIV Translational Clinical Research
指导科学家从事艾滋病毒转化临床研究
- 批准号:
10762827 - 财政年份:2023
- 资助金额:
$ 29.55万 - 项目类别:














{{item.name}}会员




